Investment Into Coptis

Coptis, a French publisher of software for cosmetic laboratories, has received funding from Extens, a fund dedicated to healthcare software publishers, and Clearsight, a Swiss investment fund

Coptis, a French publisher of software for cosmetic laboratories, has received funding from Extens, a fund dedicated to healthcare software publishers, and Clearsight, a Swiss investment fund. It will use this to consolidate in Europe, develop its product range and continue to expand operations in New York and Singapore, where it established subsidiaries in 2008 and 2016 respectively.

Coptis offers specialised software to support cosmetic laboratories and raw material manufacturers in the formulation and regulatory compliance stages. It also has a database of toxicological information on over 3,000 substances, and a document database on more than 15,000 cosmetic raw materials. The company also regularly brings together members of its ‘User Club to discuss their needs and keep on top of evolving requirements.

See more about Coptis Software Solutions for Cosmetic R&D